Also known as Christmas factor and plasma thromboplastin component.
chemXplore tracks 1 project producing coagulation factor IX, of which one is active.
1 new construction.
Owners and developers: Takeda (1)
Investors: Takeda (1)
Licensors are recorded on this project For subscribers
Three researchers honoured for creating a bispecific antibody that mimics Factor VIII, enabling subcutaneous dosing and bleed prevention irrespective of inhibitors.
Fractionation license granted; $30M pilot to open plasma donation centers and assess local PDMP manufacturing, first donation center expected 2027.
Interim FRONTIER4 data show consistent safety and efficacy of denecimig across weekly, biweekly and monthly dosing, with low injection-site reactions and high zero-bleed rates.
